These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1086116)

  • 1. Von Willebrand's disease.
    Br Med J; 1976 Sep; 2(6038):715-6. PubMed ID: 1086116
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction by factor VIII of decreased neutrophil alkaline phosphatase activity in classic haemophilia and von Willebrand's disease.
    Janković GM; Janosević S
    Haematologia (Budap); 1978-1979; 12(1-4):183-8. PubMed ID: 317061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effect of heat-treated factor VIII concentrates in von Willebrand's disease and related disorders: studies in platelet-type von Willebrand's disease].
    Takahashi H; Tatewaki W; Nagayama R; Hanano M; Takizawa S; Tamura M; Yamaguchi T; Wada K; Shibata A
    Rinsho Ketsueki; 1987 Dec; 28(12):2117-24. PubMed ID: 3133507
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High potency factor VIII concentrate: more effective than cryoprecipitate in a patient with von Willebrand's disease and inhibitor.
    Bloom AL; Peake IR; Furlong RA; Davies BL
    Thromb Res; 1979; 16(5-6):847-52. PubMed ID: 316585
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates.
    Gazengel C; Fischer AM; Schlegel N; Rothschild C; Torchet MF; Dautzenberg MD; Aujard Y
    Nouv Rev Fr Hematol (1978); 1988; 30(4):225-7. PubMed ID: 3143100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease.
    Mannucci PM; Mari D
    Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
    Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for the treatment of von Willebrand's disease.
    Sultan Y
    Prog Clin Biol Res; 1981; 72():149-62. PubMed ID: 6801684
    [No Abstract]   [Full Text] [Related]  

  • 11. Properties of post-infusion factor VIII in von Willebrand's disease.
    Muntz RH; Ekert H; Helliger H
    Thromb Res; 1974 Aug; 5(2):111-23. PubMed ID: 4547286
    [No Abstract]   [Full Text] [Related]  

  • 12. [Von Willebrand disease--type 2N (case report)].
    Zarnovicanová M; Pelikánová S
    Vnitr Lek; 2003 Apr; 49(4):319-21. PubMed ID: 12793057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of von Willebrand's disease.
    Logan LJ
    Prog Clin Biol Res; 1990; 324():279-90. PubMed ID: 2106690
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of von Willebrand's disease].
    Rafanelli D; Vannucchi AM; Morfini M
    G Clin Med; 1988 Jan; 69(1):63-6. PubMed ID: 3133271
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ultrasonic-exposed factor VIII and von Willebrand's disease].
    Casillas G; Simonetti C; Kempfer C
    Medicina (B Aires); 1981; 41 Suppl():253-6. PubMed ID: 6808289
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet-type von Willebrand's disease.
    Miller JL
    Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on molecular size distribution of factor VIII-related antigen in patients with Von Willebrand's disease and their parents].
    Mikami S; Nishino M; Yasui M; Okubo Y; Shima H; Fukui H
    Rinsho Ketsueki; 1982 Aug; 23(8):1198-204. PubMed ID: 6815349
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proceedings: Von Willebrand's disease].
    Vaccari A
    Minerva Pediatr; 1973 Dec; 25(42):1913-28. PubMed ID: 4544078
    [No Abstract]   [Full Text] [Related]  

  • 20. Von Willebrand factor and von Willebrand's disease: a complex protein and a complex disease.
    Bona RD
    Ann Clin Lab Sci; 1989; 19(3):184-9. PubMed ID: 2499240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.